Advanced Wound Care and Lymphoedema Products and Services

The NHS spends approximately £8.3 billion on wound care management, 67% of which is spent on managing unhealed wounds.

Our Advanced Wound Care and Lymphoedema Products and Services Framework Agreement supports the NHS to reduce the nursing time required to manage wound care in the community. It provides a wide choice of high-quality dressings to clinicians via a ‘just in time’ total purchase delivery model, which minimises inventory storage costs and improves overall efficiency.

Clinicians have the autonomy to select the most appropriate solution or product for their patient in the most efficient means possible, therefore improving patient outcomes and quality of life.

Formularies are developed by a multidisciplinary team of health care professionals to choose a selection of dressings. By using the online ordering system, staff can’t order anything that is not on the system, without going through the Tissue Viability team. This supports sustainability goals by reducing the amount of wastage and providing real time data reporting and online off script ordering. All dressing via the total purchase route belongs to the organisation and not the patient, therefore all dressings will be used effectively.

We are absolutely thrilled to have scooped the Health Business 2022 ‘Hospital Procurement Award’ in recognition of procurement excellence and cost-effectiveness which our Advanced Wound Care & Lymphoedema Products and Services Framework Agreement delivers. It has introduced new specialist companies to the NHS through the digital wound care and total managed services on offer. They, in turn, bring innovation in digital healthcare and new ways of working. With Integrated Care Systems (ICSs) linking social care and acute care, the framework agreement can aid the delivery of integrated care pathways as solutions offered lend themselves well to consolidating and standardising practice across an ICS.